ES2210153T3 - Analogos de nucleosidos de pirimidina de accion antiviral. - Google Patents

Analogos de nucleosidos de pirimidina de accion antiviral.

Info

Publication number
ES2210153T3
ES2210153T3 ES01928079T ES01928079T ES2210153T3 ES 2210153 T3 ES2210153 T3 ES 2210153T3 ES 01928079 T ES01928079 T ES 01928079T ES 01928079 T ES01928079 T ES 01928079T ES 2210153 T3 ES2210153 T3 ES 2210153T3
Authority
ES
Spain
Prior art keywords
alkyl
group
compound according
halogens
dideoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01928079T
Other languages
English (en)
Spanish (es)
Inventor
Christopher Mcguigan
Jan Balzarini
Erik De Clercq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rega Foundation
University College Cardiff Consultants Ltd
Cardiff University
Original Assignee
Rega Foundation
University College Cardiff Consultants Ltd
Cardiff University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rega Foundation, University College Cardiff Consultants Ltd, Cardiff University filed Critical Rega Foundation
Application granted granted Critical
Publication of ES2210153T3 publication Critical patent/ES2210153T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES01928079T 2000-05-09 2001-05-08 Analogos de nucleosidos de pirimidina de accion antiviral. Expired - Lifetime ES2210153T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0011203 2000-05-09
GBGB0011203.7A GB0011203D0 (en) 2000-05-09 2000-05-09 Chemical compounds

Publications (1)

Publication Number Publication Date
ES2210153T3 true ES2210153T3 (es) 2004-07-01

Family

ID=9891276

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01928079T Expired - Lifetime ES2210153T3 (es) 2000-05-09 2001-05-08 Analogos de nucleosidos de pirimidina de accion antiviral.

Country Status (14)

Country Link
US (1) US7019135B2 (cg-RX-API-DMAC7.html)
EP (1) EP1280813B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003532735A (cg-RX-API-DMAC7.html)
AT (1) ATE254132T1 (cg-RX-API-DMAC7.html)
AU (1) AU780879B2 (cg-RX-API-DMAC7.html)
CA (1) CA2406633A1 (cg-RX-API-DMAC7.html)
DE (1) DE60101223T2 (cg-RX-API-DMAC7.html)
DK (1) DK1280813T3 (cg-RX-API-DMAC7.html)
ES (1) ES2210153T3 (cg-RX-API-DMAC7.html)
GB (1) GB0011203D0 (cg-RX-API-DMAC7.html)
NZ (1) NZ521877A (cg-RX-API-DMAC7.html)
PT (1) PT1280813E (cg-RX-API-DMAC7.html)
TR (1) TR200302313T4 (cg-RX-API-DMAC7.html)
WO (1) WO2001085749A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
ES2172303T3 (es) 1998-01-23 2002-09-16 Newbiotics Inc Agentes terapeuticos obtenidos por catalisis enzimatica.
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
IL147749A0 (en) 1999-07-22 2002-08-14 Newbiotics Inc Methods for treating therapy-resistant tumors
GB0009486D0 (en) 2000-04-17 2000-06-07 Univ Cardiff Chemical compounds
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
AU2003298658A1 (en) 2002-11-15 2004-06-15 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
GB0609178D0 (en) * 2006-05-09 2006-06-21 Univ Cardiff Novel compounds
US7951789B2 (en) 2006-12-28 2011-05-31 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
GB201111779D0 (en) * 2011-07-08 2011-08-24 Univ Cardiff Chemical compounds
US9403863B2 (en) 2011-09-12 2016-08-02 Idenix Pharmaceuticals Llc Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
AR089650A1 (es) 2011-10-14 2014-09-10 Idenix Pharmaceuticals Inc Fosfatos 3,5-ciclicos sustituidos de compuestos de nucleotido de purina y composiciones farmaceuticas para el tratamiento de infecciones virales
EP2852604B1 (en) 2012-05-22 2017-04-12 Idenix Pharmaceuticals LLC 3',5'-cyclic phosphoramidate prodrugs for hcv infection
WO2013177195A1 (en) 2012-05-22 2013-11-28 Idenix Pharmaceuticals, Inc. 3',5'-cyclic phosphate prodrugs for hcv infection
MD20140134A2 (ro) 2012-05-22 2015-04-30 Idenix Pharmaceuticals, Inc. Compuşi ai D-aminoacizilor pentru tratamentul bolilor hepatice
PT2861611T (pt) 2012-05-25 2016-10-11 Janssen Sciences Ireland Uc Nucleósidos de espirooxetano de uracilo
WO2014052638A1 (en) 2012-09-27 2014-04-03 Idenix Pharmaceuticals, Inc. Esters and malonates of sate prodrugs
ES2674980T3 (es) 2012-10-08 2018-07-05 Idenix Pharmaceuticals Llc Análogos de 2'-cloro nucleósidos para infección por VHC
WO2014066239A1 (en) 2012-10-22 2014-05-01 Idenix Pharmaceuticals, Inc. 2',4'-bridged nucleosides for hcv infection
US9211300B2 (en) 2012-12-19 2015-12-15 Idenix Pharmaceuticals Llc 4′-fluoro nucleosides for the treatment of HCV
WO2014137930A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. Thiophosphate nucleosides for the treatment of hcv
WO2014137926A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. 3'-deoxy nucleosides for the treatment of hcv
EP2970357B1 (en) 2013-03-13 2025-01-01 Idenix Pharmaceuticals LLC Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
EP2981542B1 (en) 2013-04-01 2021-09-15 Idenix Pharmaceuticals LLC 2',4'-fluoro nucleosides for the treatment of hcv
EP3004130B1 (en) 2013-06-05 2019-08-07 Idenix Pharmaceuticals LLC. 1',4'-thio nucleosides for the treatment of hcv
US20150037282A1 (en) 2013-08-01 2015-02-05 Idenix Pharmaceuticals, Inc. D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
EP3131914B1 (en) 2014-04-16 2023-05-10 Idenix Pharmaceuticals LLC 3'-substituted methyl or alkynyl nucleosides for the treatment of hcv

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62255499A (ja) * 1986-04-28 1987-11-07 Teijin Ltd 螢光性ヌクレオシド又はヌクレオチド
GB9708611D0 (en) * 1997-04-28 1997-06-18 Univ Cardiff Chemical compounds
GB9716231D0 (en) * 1997-07-31 1997-10-08 Amersham Int Ltd Base analogues

Also Published As

Publication number Publication date
WO2001085749A1 (en) 2001-11-15
DE60101223D1 (de) 2003-12-18
US7019135B2 (en) 2006-03-28
AU5494501A (en) 2001-11-20
DK1280813T3 (da) 2004-03-22
DE60101223T2 (de) 2004-09-02
AU780879B2 (en) 2005-04-21
TR200302313T4 (tr) 2004-01-21
US20030176370A1 (en) 2003-09-18
GB0011203D0 (en) 2000-06-28
ATE254132T1 (de) 2003-11-15
NZ521877A (en) 2004-11-26
EP1280813B1 (en) 2003-11-12
PT1280813E (pt) 2004-03-31
JP2003532735A (ja) 2003-11-05
CA2406633A1 (en) 2001-11-15
EP1280813A1 (en) 2003-02-05

Similar Documents

Publication Publication Date Title
US6573247B1 (en) Anti-viral pyrimidine nucleoside analogues
US7019135B2 (en) Anti-viral pyrimidine nucleoside analogues
ES2215931T3 (es) Analogos de nucleosidos de pirimidina antiviricos.
AU2001266927B2 (en) 3'-prodrugs of 2'-deoxy-beta-L-nucleosides
US7585851B2 (en) 3′-prodrugs of 2′-deoxy-β-L-nucleosides
AU2001266927A1 (en) 3'-prodrugs of 2'-deoxy-beta-L-nucleosides
EA036892B1 (ru) Макрогетероциклические нуклеозидные производные и их аналоги, получение и применение
EP0788507B1 (en) L-pyranosyl nucleosides
AU626600B2 (en) Nucleoside derivatives
MXPA99009965A (en) Anti-viral pyrimidine nucleoside analogues
AU2007201035A1 (en) 3'-Prodrugs of 2'-deoxy-beta-L-nucleosides